Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;5(1):10.1128/microbiolspec.tnmi7-0024-2016.
doi: 10.1128/microbiolspec.TNMI7-0024-2016.

Nontuberculous Mycobacteria-Overview

Affiliations
Review

Nontuberculous Mycobacteria-Overview

Won-Jung Koh. Microbiol Spectr. 2017 Jan.

Abstract

Nontuberculous mycobacteria (NTM) are emerging pathogens that affect both immunocompromised and immunocompetent patients. The development of molecular methods has allowed the characterization of new species and the identification of NTM to the precise species and subspecies levels. The incidence and prevalence of NTM lung disease are increasing worldwide, and this syndrome accounts for the majority of clinical cases of NTM disease. Common causative organisms of pulmonary infection are the slowly growing mycobacteria Mycobacterium avium complex and Mycobacterium kansasii and the rapidly growing mycobacteria, including Mycobacterium abscessus complex. NTM lung disease often affects elderly people with chronic lung disease and may be a manifestation of a complex genetic disorder determined by interactions among multiple genes, as well as environmental exposures. To be diagnosed with NTM lung disease, patients should meet all clinical and microbiologic criteria, but the decision to start treatment is complex, requiring careful individualized analysis of risks and benefits. Clinicians should be alert to the unique aspects of NTM lung disease, including the need for proper diagnosis, the availability of advanced molecular methods for species and subspecies identification, and the benefits and limitations of recommended treatments.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Fibrocavitary form of Mycobacterium intracellulare lung disease in a 62-year-old male patient. The patient underwent antituberculosis treatment and a right upper lobectomy at 30 years of age. Chest computed tomography shows a large cavity in the right upper lung field. Note the emphysema in both lungs.
FIGURE 2
FIGURE 2
Nodular bronchiectatic form of Mycobacterium abscessus lung disease in a 63-year-old female patient. Chest computed tomography shows severe bronchiectasis in the right middle lobe and in the lingular segment of the left upper lobe. Note the multiple small nodules and tree-in-bud appearance suggesting bronchiolitis in both lungs.

References

    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416. [PubMed] - PubMed
    1. Falkinham JO, III. 2015. Environmental sources of nontuberculous mycobacteria. Clin Chest Med 36:35–41. [PubMed] - PubMed
    1. Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, Inns T, Reacher M, Haworth CS, Curran MD, Harris SR, Peacock SJ, Parkhill J, Floto RA. 2013. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 381:1551–1560. - PMC - PubMed
    1. Bryant JM, et al. 2016. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science 354:751–757. [PubMed] - PMC - PubMed
    1. Prevots DR, Marras TK. 2015. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med 36:13–34. [PubMed] - PMC - PubMed

MeSH terms

Substances